Semaglutide vs Tirzepatide: Reading Molecular Formulas Without Overclaiming

Direct answer: Semaglutide and tirzepatide are different modified peptide molecules, not interchangeable versions of the same research material. Their official descriptions give different complete molecular formulas and different lipid components. A useful molecular comparison preserves those whole-molecule fields rather than treating one compound as the other with a longer fatty-acid chain. The question here is what the published descriptions actually allow a reader to infer.

This is an independent comparison of public molecular records, not a clinical ranking or a new sample-identification experiment. Begin with the NOVABIO research catalog and GLP-based research collection for navigation; keep the official descriptions separate from catalog claims.

Start with complete molecular descriptions

Ozempic's description gives semaglutide the formula C187H291N45O59 and a stated molecular weight of 4113.58 g/mol. It describes a C18 fatty diacid attached through a spacer. Mounjaro's description gives tirzepatide the formula C225H348N48O68, a stated molecular weight of 4813.53 Da, and a C20 fatty diacid with its linker. These are the values printed in DailyMed's Ozempic section 11 and Mounjaro sections 11 and 12.1.

Retaining the formulas as complete fields prevents the lipid label from becoming shorthand for the whole compound. The original descriptions also retain the peptide scaffold, substitutions, and connectivity. A comparison that extracts only “C18” and “C20” has deliberately discarded much of the molecular record.

An atom-count difference tests a common simplification

Subtracting semaglutide's listed atom counts from tirzepatide's gives the following comparison. This is our arithmetic on the two official formulas; it is not a reaction equation, a measured mass spectrum, or a proposed synthetic route.

The source fields are the two semaglutide and tirzepatide descriptions. The independently derived difference contains additional nitrogen and oxygen as well as carbon and hydrogen. It therefore rejects the particular simplification that the whole-molecule difference is merely a two-carbon extension of an otherwise identical lipidated peptide.

The calculation does not tell us which atoms belong to which residue or linker. Formula subtraction loses connectivity, stereochemistry, and sequence order. It can disprove an overly simple identity claim without establishing a correct complete structure. That asymmetry is useful: an inexpensive consistency check can flag a bad explanation while still leaving the stronger identity question open.

A printed molecular weight is not a complete instrument target

The numerical difference between the two printed molecular-weight values is 699.95. That subtraction is a comparison of the source numbers only; it is not a newly calculated exact mass or a predicted mass-spectrometry peak separation. The source units and mass conventions must remain attached to their fields.

The University of Missouri Mass Spectrometry Facility explains that monoisotopic mass is calculated from the most abundant isotope of each element, and demonstrates its difference from molecular weight. Its worked example also states a neutral-charge assumption for the linked calculator. These conventions explain why a label number should not silently become an expected instrument result. See the facility's original Calculating Exact Masses teaching note.

A record transfer therefore needs a field for the reported quantity: a printed molecular weight, a calculated monoisotopic mass, or an experimentally reported result. Retain the calculation convention and the method's own result description where relevant. A mismatch between unlike quantities is not evidence of a failed sample, and numerical agreement between unlike quantities is not evidence of successful identification. First resolve what was compared; only then interpret agreement.

Which conclusions remain outside the comparison?

Neither the atom-count difference nor the numerical molecular-weight difference ranks receptor activity. Willard and colleagues' primary pharmacology work measures receptor-dependent responses in defined systems; it does not derive those responses by subtracting molecular formulas. See the original receptor and signaling study. The structural fields and the biological endpoints belong in linked but distinct records.

For the same reason, a whole-molecule formula is a target description rather than proof about an unknown material. A paper describing a molecule cannot establish that a separately supplied sample has that identity. Relevant characterization must connect an actual sample identifier to an appropriate procedure and result. The semaglutide sequence and structure article handles a separate coordinate question; this comparison focuses on whole-formula consistency.

Research limits and catalog documentation

No spectra were acquired, no formula was experimentally assigned, and no biological or clinical equivalence was calculated here. This comparison also leaves counter-ion, hydration, and material-content questions unresolved for any supplied lot. The Semaglutide and Tirzepatide listings identify catalog records; use Lab Results & COA for their applicable available documentation.

Frequently asked questions

Does a larger molecular-weight number mean stronger activity?

No. Molecular mass and a biological response are different quantities. An activity comparison requires the relevant experiment and endpoint.

Can the elemental difference identify a specific impurity?

No. It is a subtraction between two reference formulas, not a measurement of an impurity in either material. Assigning an impurity requires sample-specific analytical evidence.

What if a database uses a different molecular form?

Record the stated form and formula before comparing numbers. A parent molecule and a salt, adduct, or differently represented ion should not be silently treated as the same entry.

Research boundary: No dose conversion, preparation, injection, treatment, or human-use instruction is provided.